NCT07018323

Brief Summary

This is a multi-center, global, randomized, double-blind, placebo-controlled Phase 2b study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment.

Trial Health

88
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
210

participants targeted

Target at P75+ for phase_2

Timeline
12mo left

Started Jun 2025

Geographic Reach
15 countries

120 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Jun 2025May 2027

First Submitted

Initial submission to the registry

May 14, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

June 12, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

June 19, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

1.9 years

First QC Date

May 14, 2025

Last Update Submit

April 21, 2026

Conditions

Keywords

IMVT-1402Graves' diseaseThyroid-Stimulating Hormone ReceptorImmunoglobulin GAntithyroid drugImeroprubart

Outcome Measures

Primary Outcomes (1)

  • Percentage of participants who are euthyroid and off ATD at Week 26 (Dose 1)

    Week 26

Secondary Outcomes (9)

  • Percentage of participants who have triiodothyronine (T3) (Total of T3 or free triiodothyronine [FT3]) and free thyroxine (FT4) ≤ upper limit of normal (ULN) and are off ATD at Week 26 (Dose 1)

    Week 26

  • Percentage of participants who are euthyroid, off ATD, and seronegative at Week 26 (Dose 1)

    Week 26

  • Percentage of participants who are euthyroid and off ATD at Week 26 (Dose 2)

    Week 26

  • Percentage of participants who have T3 (Total T3 or FT3) and FT4 ≤ ULN and are off ATD at Week 26 (Dose 2)

    Week 26

  • Percentage of participants who are euthyroid, off ATD, and seronegative (Dose 2)

    Week 26

  • +4 more secondary outcomes

Study Arms (3)

IMVT-1402 Dose 1

EXPERIMENTAL
Drug: IMVT-1402

IMVT-1402 Dose 2

EXPERIMENTAL
Drug: IMVT-1402

Placebo

PLACEBO COMPARATOR
Drug: Placebo

Interventions

Dose 1 for 26 weeks

IMVT-1402 Dose 1

For 26 weeks

Placebo

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants with the ability to understand the requirements of the trial, provide written informed consent, and comply with the trial protocol procedures.
  • Male or female participants aged ≥ 18 years.
  • Participants with diagnosis of GD who are hyperthyroid despite ATD treatment.

You may not qualify if:

  • Have previously been successfully treated with radioactive iodine (RAI) therapy or have undergone total thyroidectomy.
  • Have an autoimmune disease other than GD requiring treatment that, in the Investigator's judgment, puts the participant at undue risk.
  • Have moderate-to-severe active thyroid eye disease (TED) and are expected to require immediate surgical intervention and/or are planning corrective surgery/irradiation or medical therapy for TED during study participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (120)

Site Number - 1015

Tucson, Arizona, 85710, United States

RECRUITING

Site Number -1014

Concord, California, 94520, United States

RECRUITING

Site Number - 1013

Aurora, Colorado, 80045, United States

RECRUITING

Site Number - 1024

Doral, Florida, 33166, United States

RECRUITING

Site Number - 1008

Hialeah, Florida, 33016, United States

RECRUITING

Site Number - 1000

Miami, Florida, 33143, United States

RECRUITING

Site Number - 1020

Columbus, Georgia, 31904, United States

RECRUITING

Site Number - 1022

Topeka, Kansas, 66606, United States

RECRUITING

Site Number - 1030

Louisville, Kentucky, 40202, United States

RECRUITING

Site Number - 1033

Jefferson City, Missouri, 65109, United States

RECRUITING

Site Number - 1004

Kansas City, Missouri, 64110, United States

RECRUITING

Site Number - 1019

St Louis, Missouri, 63110, United States

RECRUITING

Site Number - 1012

Reno, Nevada, 89511, United States

RECRUITING

Site Number - 1032

Long Island City, New York, 11106, United States

RECRUITING

Site Number - 1027

New Hyde Park, New York, 11434, United States

RECRUITING

Site Number - 1009

New York, New York, 10022, United States

RECRUITING

Site Number - 1018

Williamsville, New York, 14221, United States

RECRUITING

Site Number - 1010

Chapel Hill, North Carolina, 27514, United States

RECRUITING

Site Number - 1026

Hickory, North Carolina, 28601, United States

RECRUITING

Site Number - 1001

Morehead City, North Carolina, 27577, United States

RECRUITING

Site Number - 1034

Raleigh, North Carolina, 27612, United States

RECRUITING

Site Number - 1007

Oklahoma City, Oklahoma, 73134, United States

RECRUITING

Site Number - 1017

Memphis, Tennessee, 38119, United States

RECRUITING

Site Number - 1029

Dallas, Texas, 75224, United States

RECRUITING

Site Number - 1002

El Paso, Texas, 79935, United States

RECRUITING

Site Number - 1003

Fort Worth, Texas, 76132, United States

RECRUITING

Site Number - 1031

Houston, Texas, 77030, United States

RECRUITING

Site Number - 1028

Houston, Texas, 77054, United States

RECRUITING

Site Number -1023

Irving, Texas, 75031, United States

RECRUITING

Site Number - 1021

Irving, Texas, 75039, United States

RECRUITING

Site Number - 1025

McKinney, Texas, 75069, United States

RECRUITING

Site Number - 1011

San Antonio, Texas, 78231, United States

RECRUITING

Site Number - 1016

Norfolk, Virginia, 23510, United States

RECRUITING

Site Number - 5105

Sydney, New South Wales, 2050, Australia

RECRUITING

Site Number - 5103

Warrawong, New South Wales, 2502, Australia

RECRUITING

Site Number - 5101

Brisbane, Queensland, 4101, Australia

RECRUITING

Site Number - 5107

Douglas, Queensland, 4814, Australia

RECRUITING

Site Number - 5100

Southport, Queensland, 4222, Australia

RECRUITING

Site Number - 5102

Box Hill, Victoria, 3128, Australia

RECRUITING

Site Number - 5104

Geelong, Victoria, 3220, Australia

RECRUITING

Site Number - 5108

Perth, 6009, Australia

RECRUITING

Site Number - 5109

Saint Leonards, 2065, Australia

RECRUITING

Site Number - 5505

Santo André, São Paulo, 09060-870, Brazil

RECRUITING

Site Number - 5610

Sofia, Sofia-Grad, 1431, Bulgaria

RECRUITING

Site Number - 5613

Dobrich, 7002, Bulgaria

RECRUITING

Site Number - 5606

Plovdiv, 4001, Bulgaria

RECRUITING

Site Number - 5607

Plovdiv, 4002, Bulgaria

RECRUITING

Site Number - 5601

Sliven, 8800, Bulgaria

RECRUITING

Site Number - 5612

Smolyan, 4700, Bulgaria

RECRUITING

Site Number - 5604

Sofia, 1233, Bulgaria

RECRUITING

Site Number - 5609

Sofia, 1431, Bulgaria

RECRUITING

Site Number - 5608

Sofia, 1680, Bulgaria

RECRUITING

Site Number- 5605

Sofia, 1750, Bulgaria

RECRUITING

Site Number - 5602

Varna, 9002, Bulgaria

RECRUITING

Site Number - 5603

Varna, 9020, Bulgaria

RECRUITING

Site Number - 5611

Varna, 9020, Bulgaria

RECRUITING

Site Number - 5600

Yambol, 8600, Bulgaria

RECRUITING

Site Number - 3203

Náchod, 547 01, Czechia

RECRUITING

Site Number - 3201

Prague, 149 00, Czechia

RECRUITING

Site Number - 3200

Prague, 181 00, Czechia

RECRUITING

Site Number - 3202

Prague, 190 14, Czechia

RECRUITING

Site Number - 8004

Imereti, 4600, Georgia

RECRUITING

Site Number - 8003

Tbilisi, 0114, Georgia

RECRUITING

Site Number - 8000

Tbilisi, 0145, Georgia

RECRUITING

Site Number - 8002

Tbilisi, 0159, Georgia

RECRUITING

Site Number - 8001

Tbilisi, 0160, Georgia

RECRUITING

Site Number - 8005

Tbilisi, 0186, Georgia

RECRUITING

Site Number - 3902

Athens, 106 76, Greece

RECRUITING

Site Number - 3900

Athens, 115 27, Greece

RECRUITING

Site Number - 3901

Athens, 115 28, Greece

RECRUITING

Site Number - 4202

Ramat Gan, Central District, 5265601, Israel

RECRUITING

Site Number - 4205

Haifa, Haifa District, 3104802, Israel

RECRUITING

Site Number - 4203

Haifa, Haifa District, 3109601, Israel

RECRUITING

Site Number - 4209

Nahariya, Northern District, 2210001, Israel

RECRUITING

Site Number - 4206

Tzfat, Northern District, 1311001, Israel

RECRUITING

Site Number - 4211

Beersheba, Southern District, 8410101, Israel

RECRUITING

Site Number - 4201

Jerusalem, 9103102, Israel

RECRUITING

Site Number - 4204

Jerusalem, 9112001, Israel

RECRUITING

Site Number - 4210

Kfar Saba, 4428164, Israel

RECRUITING

Site Number - 4200

Petah Tikva, 4941492, Israel

RECRUITING

Site Number - 4208

Rehovot, 7661041, Israel

RECRUITING

Site Number - 4207

Tel Aviv, 6423906, Israel

RECRUITING

Site Number - 6005

Rozzano, Milan, 20089, Italy

RECRUITING

Site Number - 6003

Milan, 20132, Italy

RECRUITING

Site Number - 6006

Pavia, 27100, Italy

RECRUITING

Site Number - 6001

Rome, 135, Italy

RECRUITING

Site Number - 6002

Udine, 33100, Italy

RECRUITING

Site Number - 4600

Ogre, LV-5001, Latvia

RECRUITING

Site Number - 4602

Riga, LV-1006, Latvia

RECRUITING

Site Number - 4603

Riga, LV-1050, Latvia

RECRUITING

Site Number - 4604

Sigulda, LV-2150, Latvia

RECRUITING

Site Number - 4601

Ventspils, LV-3601, Latvia

RECRUITING

Site Number - 2003

Rotterdam, South Holland, 3045 PM, Netherlands

RECRUITING

Site Number - 2200

Rotterdam, South Holland, 3079 DZ, Netherlands

RECRUITING

Site Number - 2201

Rotterdam, South Holland, 3083 AN, Netherlands

RECRUITING

Site Number - 2202

Zwijndrecht, South Holland, 3318 AT, Netherlands

RECRUITING

Site Number - 3301

Auckland, 2025, New Zealand

RECRUITING

Site Number - 3300

Wellington, 6242, New Zealand

RECRUITING

Site Number - 3004

Bialystok, Podlaskie Voivodeship, 15-276, Poland

RECRUITING

Site Number - 3001

Szczecin, West Pomeranian Voivodeship, 71-252, Poland

RECRUITING

Site Number - 3002

Bydgoszcz, 85-605, Poland

RECRUITING

Site Number - 3010

Chorzów, 41-516, Poland

RECRUITING

Site Number - 3007

Kielce, 25-734, Poland

RECRUITING

Site Number - 3000

Lublin, 20-607, Poland

RECRUITING

Site Number - 3005

Olsztyn, 10-117, Poland

RECRUITING

Site Number - 3009

Opole, 45-301, Poland

RECRUITING

Site Number - 3006

Poznan, 60-693, Poland

RECRUITING

Site Number - 3008

Warsaw, 02-482, Poland

RECRUITING

Site Nnumber - 3003

Wroclaw, 50-367, Poland

RECRUITING

Site Number - 4500

Daegu, 42415, South Korea

RECRUITING

Site Number - 4503

Goyang, 410-77, South Korea

RECRUITING

Site Number - 4504

Guri-si, 11923, South Korea

RECRUITING

Site Number - 4501

Seoul, 02841, South Korea

RECRUITING

Site Number - 4506

Seoul, 03181, South Korea

RECRUITING

Site Number - 4505

Seoul, 05278, South Korea

RECRUITING

Site Number - 7009

Cornwell, TR1 3LJ, United Kingdom

RECRUITING

Site Number - 7006

London, SE1 9RT, United Kingdom

RECRUITING

Site Number - 7001

London, W2 1NY, United Kingdom

RECRUITING

Site Number - 7010

Salford, M6 8HD, United Kingdom

RECRUITING

Site Number - 7008

Surrey, GU2 7XX, United Kingdom

RECRUITING

MeSH Terms

Conditions

Graves Disease

Condition Hierarchy (Ancestors)

ExophthalmosOrbital DiseasesEye DiseasesGoiterThyroid DiseasesEndocrine System DiseasesHyperthyroidismAutoimmune DiseasesImmune System Diseases

Central Study Contacts

Central Study Contact

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2025

First Posted

June 12, 2025

Study Start

June 19, 2025

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations